Ex vivo expansion of CD34+ peripheral blood progenitor cells: Implications for the expansion of contaminating epithelial tumor cells

Blood

Volumn 88, Issue 7, 1996, Pages 2707-2713

  Vogel, Wichard ^b   Behringer, Dirk ^b   Scheding, Stefan ^b   Kanz, Lothar ^b   Brugger, Wolfram ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYTOKERATIN; EPIRUBICIN; ERYTHROPOIETIN; ETOPOSIDE; IFOSFAMIDE; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR;

ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER TRANSPLANTATION; CELL GROWTH; CLINICAL ARTICLE; CONTAMINATION; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; PRIORITY JOURNAL;

EID: 0029793470     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.7.2707.bloodjournal8872707     Document Type: Article

References (28)

1. Kessinger A, Armitage JO: The evolving role of autologous peripheral stem cell transplantation following high-dose chemotherapy for malignancies. Blood 77:211, 1991
2. Sheridan WP, Begley CG, Juttner C, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1:640, 1992
3. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet DS, Winter C, Jansen J, Akared L, Copeland E, Kanh DJ, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993
4. Shpall EJ, Jones RB: Release of tumor cells from bone marrow. Blood 83:623, 1994 (editorial)
5. Moss TJ, Sanders DG, Lasky LC, Bostrom B: Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 76:1879, 1990
6. Passos-Coelho JL, Ross AA, Moss TJ, Davis JM, Huelsmakm PM, Noga SJ, Davidson NE, Kennedy MJ: Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 85:1138, 1995
7. Shpall EJ, Jones RB, Bearman SJ, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Kami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
8. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994
9. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
10. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994
11. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF, Hester J, Körbling M, Durett A, Moen R, Berenson R, Heimfeld J, Hamer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
12. Gribben JG, Freedman AS, Neuberg D, Denis SD, Roy DC, Blöake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler AM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B cell lymphoma. N Engl J Med 325:1525, 1991
13. Berenson RJ, Shpall EJ, Franklin WA, Jones RB, Bearman SI, Purdy MH, Cagnoni P, Heimfeld S: Transplantation of CD34 positive marrow and/or peripheral blood progenitor cells into breast cancer patients following high-dose chemotherapy. Bone Marrow Transplant 15:S32, 1995 (abstr 153, suppl 2)
14. Schulze R, Schulze M, Wischnik A, Ehnle S, Doukas K, Behr W, Schlimok G: Tumor cell contamination of peripheral blood stem cell transplants (PBSCT) and/or bone marrow (BM) in high risk breast cancer patients (N > 10). Blood 86:234a, 1995 (suppl 1, abstr 923)
15. Krämer A, Haas R, Murea S, Kirsch M, Pantel K, Riethmüller G, Bastert W, Hunstein W: Mobilization of peripheral blood progenitor cells and detection of minimal residual disease in patients with breast cancer. Blood 84:108a, 1994 (suppl 1, abstr 419)
16. Ross AA, Loudovaris M, Hazelton B, Weaver CH, Schwartzberg L, Bender JG: Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients. Exp Hematol 23:1478, 1995
17. Brugger W, Scheding S, Vogel W, Kanz L: Purging of peripheral blood progenitor cells. Review. Ann Oncol 7:11, 1996 (suppl 2)
18. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994
19. + cells into the myeloid lineage. Blood 80:1405, 1992
20. + progenitor cells by stem cell factor, interleukin-1β, IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81:2579, 1993
21. + cells from patients with stage IV breast cancer. Blood 84:3567, 1994
22. + immunoselection and ex vivo expansion of peripheral blood progenitor cells. Blood 84:2898, 1994
23. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
24. Kessinger A: Circulating stem cells - Waxing hematopoietic. N Engl J Med 333:315, 1995
25. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 85:1647, 1995
26. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
27. Mann SL, Joshi SS, Weisenburger DD, Armitage JO, Kessinger MA, Vaughan WP, Sharp JG: Detection of tumor cells in histologically normal bone marrow of autologous transplant patients using culture techniques. Exp Hematol 14:541, 1986 (abstr 771)
28. Bock TA, Orlic D, Dunbar CE, Broxmeyer HE, Bodine DM: Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 182:2037, 1995